Ambev S.A.
ABEVNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $2.77 Prior regular-session close from the quote source.
- $2.78–$2.82 Regular-session low and high so far today.
- 11.1M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $2.28–$3.45 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own ABEV if its route-to-market scale and brands can restore organic growth without sacrificing margins.
ABEV price history
Loading recent earnings…
Investment thesis
What must happen next
Ambev’s local beer brands, packaging system and dense trade distribution continue to support price/mix and prevent input-cost shocks from permanently compressing unit economics.StrengtheningMateriality: High
FY2025 IFRS annual gross_profit was BRL45.378 billion, only slightly below FY2024 despite FY2025 revenue declining. If this holds, Ambev can protect gross profit even in slower volume periods; if it breaks, revenue growth would have to be bought with promotions and lower margins.
Watch: Heineken or Grupo Petrópolis wins durable shelf space, tap handles or distributor mindshare in Ambev’s core Brazilian regions.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 IFRS annual gross_profit was BRL45.378 billion, only slightly below FY2024 despite FY2025 revenue declining.
Open source ↗Ambev’s brewing, procurement and logistics scale allow stable gross economics to become operating leverage rather than being absorbed by permanent selling and distribution expense escalation.StrengtheningMateriality: High
FY2025 IFRS annual operating_income rose to BRL23.318 billion from BRL21.802 billion in FY2024 while revenue declined. Operating leverage is the bridge from a defensible beverage franchise to owner earnings; if it fades, the company can look profitable at gross margin but fail to compound.
Watch: A sustained price war with Heineken or Grupo Petrópolis requires higher trade spend, cooler investment and advertising just to defend share.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 IFRS annual operating_income rose to BRL23.318 billion from BRL21.802 billion in FY2024 while revenue declined.
Open source ↗The breadth of Ambev’s beer-led beverage portfolio and everyday-consumption occasions keep the business from becoming structurally volume negative, so revenue weakness remains cyclical rather than permanent.HoldingMateriality: Medium
FY2025 IFRS annual revenue of BRL88.243 billion remained above FY2023 revenue of BRL79.737 billion and FY2022 revenue of BRL79.709 billion. If demand is merely cyclical, margin gains can compound on a recovering revenue base; if demand is structurally impaired, the business becomes a shrinking cash harvest.
Watch: Brazilian or Latin American consumers trade down persistently to lower-priced competitors or informal channels.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 IFRS annual revenue of BRL88.243 billion remained above FY2023 revenue of BRL79.737 billion and FY2022 revenue of BRL79.709 billion.
Open source ↗Ambev’s cash-generative model and conservative balance sheet give it room to fund distribution, packaging and brand investment while still returning capital without relying on leverage.StrengtheningMateriality: Medium
FY2025 IFRS annual operating_cash_flow was BRL24.450 billion, exceeding FY2025 IFRS annual net_income of BRL15.988 billion. If cash conversion holds, shareholders can benefit from both reinvestment and distributions; if it breaks, the company may have to choose between defending the franchise and paying owners.
Watch: Distributor or retailer financing needs rise, creating a working-capital drain before sales are collected.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 IFRS annual operating_cash_flow was BRL24.450 billion, exceeding FY2025 IFRS annual net_income of BRL15.988 billion.
Open source ↗Margin and cash-flow improvements must reach each share rather than being absorbed by tax, FX, related-party capital allocation or dilution.StrengtheningMateriality: Medium
FY2025 IFRS annual eps_diluted was BRL0.9885, up from BRL0.9129 in FY2024. For ADR holders, the business can look healthy while per-share value disappoints if earnings do not translate cleanly to each share.
Watch: Brazilian real depreciation reduces ADR-level value even if local-currency EPS rises.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 IFRS annual eps_diluted was BRL0.9885, up from BRL0.9129 in FY2024.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Ambev’s local beer brands, packaging system and dense trade distribution continue to support price/mix and prevent input-cost shocks from permanently compressing unit economics. If this holds, Ambev can protect gross profit even in slower volume periods; if it breaks, revenue growth would have to be bought with promotions and lower margins.
Ambev’s brewing, procurement and logistics scale allow stable gross economics to become operating leverage rather than being absorbed by permanent selling and distribution expense escalation. Operating leverage is the bridge from a defensible beverage franchise to owner earnings; if it fades, the company can look profitable at gross margin but fail to compound.
The breadth of Ambev’s beer-led beverage portfolio and everyday-consumption occasions keep the business from becoming structurally volume negative, so revenue weakness remains cyclical rather than permanent. If demand is merely cyclical, margin gains can compound on a recovering revenue base; if demand is structurally impaired, the business becomes a shrinking cash harvest.
Ambev’s cash-generative model and conservative balance sheet give it room to fund distribution, packaging and brand investment while still returning capital without relying on leverage. If cash conversion holds, shareholders can benefit from both reinvestment and distributions; if it breaks, the company may have to choose between defending the franchise and paying owners.
Margin and cash-flow improvements must reach each share rather than being absorbed by tax, FX, related-party capital allocation or dilution. For ADR holders, the business can look healthy while per-share value disappoints if earnings do not translate cleanly to each share.
All standing thesis claims
Original report summary
its route-to-market scale and brands can restore organic growth without sacrificing margins.
Bull case and bear case
Bull case and bear case for Ambev S.A.
Where the evidence on Ambev S.A. stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.
Bull case: what the evidence supports
Ambev’s local beer brands, packaging system and dense trade distribution continue to support price/mix and prevent input-cost shocks from permanently compressing unit economics.
Ambev’s brewing, procurement and logistics scale allow stable gross economics to become operating leverage rather than being absorbed by permanent selling and distribution expense escalation.
The breadth of Ambev’s beer-led beverage portfolio and everyday-consumption occasions keep the business from becoming structurally volume negative, so revenue weakness remains cyclical rather than permanent.
Ambev’s cash-generative model and conservative balance sheet give it room to fund distribution, packaging and brand investment while still returning capital without relying on leverage.
Margin and cash-flow improvements must reach each share rather than being absorbed by tax, FX, related-party capital allocation or dilution.
Bear case: what would count against it
Heineken or Grupo Petrópolis wins durable shelf space, tap handles or distributor mindshare in Ambev’s core Brazilian regions.
A sustained price war with Heineken or Grupo Petrópolis requires higher trade spend, cooler investment and advertising just to defend share.
Brazilian or Latin American consumers trade down persistently to lower-priced competitors or informal channels.
Thesis-Break Engine
Thesis-break watch · Ambev S.A.
Loading the break-condition record for Ambev S.A..
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
Ambev S.A. filed an SEC report on 2026-10-29: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Ambev S.A. filed an SEC report on 2026-10-22: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Ambev S.A. filed an SEC report on 2026-10-14: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Heineken or Grupo Petrópolis wins durable shelf space, tap handles or distributor mindshare in Ambev’s core Brazilian regions.
- A sustained price war with Heineken or Grupo Petrópolis requires higher trade spend, cooler investment and advertising just to defend share.
- Brazilian or Latin American consumers trade down persistently to lower-priced competitors or informal channels.
- Distributor or retailer financing needs rise, creating a working-capital drain before sales are collected.
- Brazilian real depreciation reduces ADR-level value even if local-currency EPS rises.
ABEV news
Loading headlines…
Financial statements
ABEV income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
ABEV: quick answers
- Have members of Congress traded ABEV?
- 26 trades in ABEV have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed ABEV trade
